SAT409 Sublingual Estradiol Only, Compared To Combined Oral Estradiol And Cyproterone Acetate,Offers No Apparent Advantage For Gender Affirming Hormone Therapy (GHAT), In Treatment Naïve Transwomen: Results Of A Prospective Pilot Study

Disclosure: I. Yaish: None. G. Gindis: None. Y. Greenman: None. G. Shefer: None. A. Buch: None. M. Arbiv: None. Y. Moshe: None. Y. Sofer: None. K.M. Tordjman: None. Background: The standard approach for Gender-Affirming Hormone Therapy (GAHT) oftransgender women (TW) in Israel is oral estradiol (OE)...

Descripción completa

Detalles Bibliográficos
Autores principales: Yaish, Iris, Gindis, Guy, Greenman, Yona, Shefer, Gabi, Buch, Assaf, Arbiv, Mira, Moshe, Yaffa, Sofer, Yael, Tordjman, Karen Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Transgender Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554417/
http://dx.doi.org/10.1210/jendso/bvad114.2080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554417/
http://dx.doi.org/10.1210/jendso/bvad114.2080

Ejemplares similares